Biocracked
Approach: 3, the human outcome, here as an animal-science moment. Palette: C, natural.

An old female lab mouse with slightly greying, ruffled fur sits upright on a researcher's open gloved palm, photographed at eye level in a close side-on view with a shallow depth of field. Behind it, a softly blurred animal facility window pours in real morning daylight, giving the scene a pale green-grey and warm-wood setting. The nitrile glove is a vivid electric green (#00e676), the single saturated accent. The mouse's whiskers and pink ears catch the light, and the researcher's white coat sleeve is just visible. Tones are natural: skin, soft cream bedding, sage walls. The mood is calm, careful and quietly hopeful, and it conveys age and care rather than drama. The image has no text, no labels and no readable writing.
Longevity

Abin da ke cikin Ozempic ya tsawaita rayuwar berayen da suka tsufa – Ga dalilin

Dr. Synapse · · 4 min read

Semaglutide, sinadarin da ke cikin Ozempic da Wegovy, ya nuna wani abu da ba a saba gani ba a berayen da suka tsufa: alama ce cewa yana rage saurin tsufar jiki kuma yana tsawaita rayuwa. Amma an samu wannan sakamakon ne a yanayi da ba a daidaita da rage cin abinci kawai ba.

Binciken da ke cikin takardar da aka wallafa a Nature (2026) ya fito daga masu bincike a UC Berkeley tare da haɗin gwiwa daga Jami'ar Copenhagen da National Institute on Aging. Takardar tana magana ne kawai akan beraye, don haka ya kamata a karanta ta a matsayin binciken dabbobi. Duk da haka, tana ba da haske kan dalilin da ya sa magungunan GLP‑1 ke ba da fa'ida fiye da sarrafa sukari da nauyi.

Abin da masu binciken suka yi a zahiri

Ƙungiyar ta ba berayen C57BL/6 mata masu watanni 20 maganin semaglutide na tsawon watanni uku. Wannan yana nufin an ba su maganin a ƙarshen rayuwarsu a dakin gwaje‑gwaje, ba a farkon ƙuruciyarsu ba.

A cewar takaitaccen bayani (abstract), maganin ya:

  • inganta aikin jiki
  • rage alamun tsufa
  • daidaita masu gano abinci da ƙwayoyin halitta masu alaka da tsufa

Lokacin da maganin ya ci gaba, rayuwar berayen ta tsawaita. Takardar ba ta ba da adadin ƙaruwa ba, don haka ba a san ainihin tasirin ba.

Kwatanta da rage kalori (CR)

Rage kalori (CR) shine hanyar da aka tabbatar da ita wajen tsawaita rayuwa a dabbobi na dakin gwaje‑gwaje. CR yana rage alamun tsufa da cututtuka masu alaka da shekaru. Saboda magungunan GLP‑1 ke rage sha’awar abinci, tambaya ta taso: shin semaglutide yana aiki ne a matsayin CR ko kuma wani abu daban?

Masu binciken sun kwatanta sakamakon da CR da aka daidaita. Sakamakon ya kasance kamar haka:

  • Daidaito da CR: Semaglutide ya kiyaye mafi yawan fa'idodin CR, kamar rage raguwar aiki da ke faruwa da shekaru.
  • Inda ya bambanta: A fannin sha’awar abinci, ƙwaƙwalwar sarri, da sarrafa sukari, berayen da aka ba su semaglutide sun nuna ci gaba sama da matakin asali, kuma suka fi CR nasara.

Masu rubutun sun bayyana kunna GLP‑1R a matsayin “mimetic na rage kalori” da ke nuna tasiri “saban da na rage cin abinci kawai”. A wasu kalmomi, rage cin abinci na iya zama wani ɓangare na sakamakon, amma ba shine kadai ba.

Me yasa wannan ke da muhimmanci

Magungunan GLP‑1 sun nuna fa'idoji fiye da sarrafa sukari da nauyi, amma dalilan kimiyya na waɗannan fa'idojin ba a fahimce su sosai ba. Wannan binciken na ba da wata fahimta: maganin na iya shiga hanyoyin da suka shafi gano abinci da sarrafa tsufa, waɗanda CR ke amfani da su. Idan haka ne, wasu fa'idodin da aka gani a marasa lafiya na iya kasancewa sakamakon rage saurin tsufar jiki maimakon tasirin gefe‑gefe.

Lura cewa wannan ra'ayi yana dogara ne kacokali akan bayanan beraye, ba a tabbatar da shi a mutane ba.

Abin da wannan ba ya nufin ga mutane

Ƙuntatawa

  • Binciken dabbobi ne. Sakamakon beraye ba koyaushe ke nufin mutane ba, kuma wannan binciken ba ya tabbatar da cewa semaglutide zai tsawaita rayuwar ɗan adam.
  • Berayen mata kawai. Takardar ta bayyana cewa an yi amfani da berayen mata, don haka ba za a ɗauka ya shafi maza ba.
  • Iri da shekaru guda. An yi amfani da berayen C57BL/6 da aka fara magani a watanni 20.
  • Fara a ƙarshen rayuwa a beraye ba yana nufin haka a mutane. Canza watanni na beraye zuwa shekaru a mutane ba abu ne da za a iya yi da sahihanci ba.
  • Rikicin sha'awa. Jami'ar California ta gabatar da takardar izinin mallakar fasaha kan masu kunna GLP‑1 don tsufar lafiya. Wannan ba ya kawar da kimar binciken, amma yana da kyau a sani.

Ga waɗanda ke riga suna shan maganin GLP‑1 don ciwon suga ko kiba, wannan binciken ba hujja ba ne da zai tabbatar da cewa suna rage tsufarsu. Hakanan ba dalili bane na fara ko dakatar da magani.

Abubuwan da za a iya amfani da su: kima, lokaci, da wa ya dace

  • Kima: Takardar ba ta ba da kima ba, kuma ba za a iya juya kima daga beraye zuwa mutum da ƙididdiga kawai ba. Babu wani shaida da ke tallafa “kima ta anti‑ageing” na semaglutide.
  • Lokaci: A beraye, an fara magani a ƙarshen rayuwa (watanni 20) kuma an ci gaba da shi na tsawon watanni uku. Wannan tsari ne na bincike, ba shawara ga mutane ba.
  • Wa ya dace: Semaglutide a yanzu an amince da shi don ciwon suga na nau’in 2 da kiba. Babu wani shaida a cikin wannan binciken da ya nuna shi a matsayin maganin tsawon rai ga mutane, kuma masu binciken sun jaddada cewa wannan matakin na kimiyya ne, ba na kulawa ba.

Saƙon da ya fi dacewa yanzu shi ne a ci gaba da amfani da maganin GLP‑1 bisa ga shawarar likita, a kan dalilan da aka tabbatar da su, kuma a duba tsawon rai a matsayin wani ƙari da ke buƙatar gwaje‑gwaje a mutane.

Abin da za a sa ido a gaba

Matakai na gaba sun haɗa da maimaita sakamakon, gwada maza da sauran nau’o’in beraye, da kuma gudanar da gwaje‑gwajen mutane da za su auna tasirin tsufa maimakon kawai nauyi ko sukari. Sakamakon da semaglutide ya wuce CR a sha’awar abinci, ƙwaƙwalwar sarri, da sarrafa sukari na nuni da cewa kunna GLP‑1 na iya haifar da canje‑canje na biochemical da suka wuce rage kalori kadai.

A halin yanzu, wannan alama ce mai ƙarfi a matakin pre‑clinical a mujallar da ta shahara, kuma tunatarwa cewa magungunan da ke canza halayen cin abinci na iya tabo wani abu mafi zurfi fiye da rage cin abinci kawai.

Source: Feng Y, et al. “Late‑life semaglutide treatment slows ageing and extends lifespan in female mice.” Nature 2026;657(8131):469‑476. doi:10.1038/s41586-026-10940-7.

Original study

Read the original research on pubmed.ncbi.nlm.nih.gov →

This article summarizes published research for general information. It is not medical advice.

DS

Written by

Dr. Synapse

Dr. Synapse writes for Biocracked: biohacking science, longevity & human performance.

Related Articles

Approach: Macro science, the human outcome angle through tissue. Palette: D, bold color field.

Extreme close-up of a cross-section of raw beef thigh muscle, used as a stand-in for human thigh tissue. It is shot straight on and slightly from above, on a saturated tomato-red seamless backdrop. Fine white fat marbling threads run through the dark red muscle fibers. On one half the marbling is dense and lacy, and on the other it is sparse and clean, so the contrast reads as a before and after. A thin, translucent calipers-style steel ruler lies along the edge, with no markings readable. Lighting is soft, directional studio light from the upper left, with crisp highlights on the glistening fibers and gentle warm shadows. A single small electric green surgical marker dot sits on the tissue. The mood is analytical, tense and uncertain, with shallow depth of field and sharp detail on the fat texture.
longevity

Semaglutide Mai Girma da Tsokar Cinyoyi: Abinda MRI Ya Nuna

BY HELIX WARD ·

Binciken MRI da aka yi a cikin gwajin STEP UP ya duba abin da ke faruwa bayan makonni 72 na amfani da semaglutide mai ƙarfi (7.2 mg) akan tsarin jiki, ciki har da tsokar cinyoyi. An sami raguwar kitse sosai, kusan lita 11 idan aka kwatanta da placebo, kuma kitse a cikin tsokar cinyoyi ya ragu sosai. Girman tsokar cinyoyi ya ragu da kusan lita 1.1, canjin da bai kai matsayin ƙididdiga ba (p = 0.07) amma tazara na dogara tana nuni da asara. Tunda an duba mutum 55 kawai, tare da placebo guda shida, kuma kamfanin Novo Nordisk ya shiga cikin binciken, sakamakon na nuni ne kawai ba tabbatacce ba.

**Approach:** Lab in action. **Palette:** Bold color field, mustard yellow.

A close, slightly high three-quarter view of a hand in a magenta-purple nitrile glove holding a clear 12-well cell culture plate. Each well is filled with salmon-pink culture medium. A multichannel pipette hovers over one well, with a single droplet caught just before it falls. The background is a seamless, saturated mustard-yellow surface and wall, with a soft shadow under the plate. Bright, even studio light comes from the upper left, giving crisp highlights on the plastic rims and a soft glow through the liquid. The depth of field is shallow, so the far wells blur gently. A tiny electric-green cap on a tube sits in the corner of the frame. The mood is calm, precise and curious, with a clean, graphic, editorial feel. No text or labels.
peptides

Semaglutide Ba Ya Rage Kwayoyin Tsoka na Dan Adam. To Me Ya Sa Akwai Rashin Tsoka?

BY DR. SYNAPSE ·

Shin semaglutide yana lalata tsokar ka? Sabon binciken *GeroScience* ya gwada maganin kai tsaye a kan ƙwayoyin tsoka na manya masu kiba, inda ba a ga wata alamar lalacewa ba. Babu alamar atrophy, babu canjin secretome, har ma GIP ya ƙara kauri ga myotubes bayan kwanaki takwas. Semaglutide ya rage ɗan ƙanƙanta samar da ATP ta glycolysis, amma GLP‑1 receptors ba su yawaita ba a ƙwayoyin. Sakamakon na nuni da cewa asarar tsoka da ake gani a asibiti na da alaƙa da ƙarancin kalori da rage ɗagawa, ba da kai tsaye ga maganin ba.

**Approach: Conceptual metaphor. Palette: D, bold color field.**

A single clear glass of water sits on a saturated mustard-yellow backdrop, shot at a slight low three-quarter angle. A hand-held pen injector rests beside it, its body a matte white with a small electric green dial ring as the only green accent. Hard but clean studio light from the upper left throws a crisp, defined shadow across the yellow surface. Through the glass, the injector is refracted into two slightly offset images, suggesting a signal that is split and hard to read. The mood is calm, questioning and balanced, with no drama. The background is fully warm and bright, with no blue cast. The surface has a subtle paper-like texture. There is no text, no label and no face.
metabolism

Shin Ozempic da Mounjaro Suna Haifar da Tunani na Kashe Kai? Abin da Bincike 20 Ya Gano

BY DR. SYNAPSE ·

Shin magungunan Ozempic da Mounjaro na ƙara haɗarin damuwa, fargaba ko tunani na kashe kai? Bincike mai tsari da aka wallafa a *Rambam Maimonides Medical Journal* ya nuna cewa hujjojin da suka fi ƙarfi ba su tabbatar da wannan haɗari ba. Gwaje‑gwajen da aka yi da tsarin bazuwar ba su nuna ƙaruwa a haɗarin tunani na kashe kai, damuwa ko fargaba ga masu amfani da semaglutide ko tirzepatide ba. Sai dai akwai buƙatar ci gaba da sa ido ga waɗanda ke da tarihin cutar kwakwalwa.

Approach: conceptual metaphor. Palette: D, bold color field.

A single steel dumbbell sits in the center of a saturated tomato-red seamless backdrop. A thick, taut rope of frayed tan fibers wraps around its handle, and a few strands are visibly thinning and unraveling at one end while the rest stay dense and intact, standing for muscle being preserved while weight drops. Shot at a low three-quarter angle with a shallow depth of field, so the knurled grip texture is crisp and the background melts into smooth red. Hard, directional studio light from the upper left casts a sharp, short shadow on the glossy red surface. One thin electric green cable tie is cinched around the rope. The mood is punchy, tense and editorial, with no people and no text.
peptides

Menene Za a Hada da Tirzepinide Don Kula da Tsoka? Kure Sun Ba da Shaida

BY NOVA CHEN ·

Tirzepinide na rage kiba cikin sauri, amma me ke faruwa da tsokar jiki? Wani sabon bincike a *The Journal of Physiology* ya gwada maganin kai tsaye tare da cin abinci a lokutan iyaka (TRF) da horon ƙarfi. Haɗin gwiwar ya haifar da ragin nauyi da kitse mai sauri, horon ƙarfi ya kiyaye tsoka da ƙarfi, yayin da TRF da tirzepinide suka inganta sarrafa sukari. Sai dai fa'idar hanta ba ta bambanta ba a dukkan hanyoyin. Wannan bincike na dabbobi ne kawai a kan ƙure masu kiba, don haka a ɗauke shi a matsayin alamar bege, ba a matsayin tsarin da za a bi a mutane ba.

This page is available in